How do you manage leptomeningeal carcinomatosis from a metastatic solid tumor?
Do you prefer WBRT, IT chemo or targeted systemic therapy and what is your preference on the sequence of therapies?
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · University of Nebraska Medical Center
Answered on
Several factors are usually considered prior to deciding how to manage patients with leptomeningeal carcinomatosis from a metastatic solid tumor. These factors are tumor type, performance status, neurological status, the bulk of CSF disease, the extra-cranial tumor burden as well as the chance of th...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University of Nebraska Medical Center
Answered on
This article has a lot of issues.
First of all, authors claimed that this was a phase II clinical trial. However, there was no sample size justification. I believe that this was at most a retrospective analysis of prospectively collected data. And they included only 11 breast cancer patients.
Second, ...
Join for free or sign in to see the full answer